Full Approval and New Combination for Amivantamab-vmjw
The FDA has approved amivantamab-vmjw, both alone and in combination with chemotherapy, for the treatment of certain non-small cell lung cancers. The U.S. Food and Drug Administration (FDA) has approved amivantamab-vmjw (Rybrevant), in combination...